Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-97.57	40.90	-1683.75
Graham Fair Price	21.92	109.62	89.91
PEG	-53.30	0.21	-0.45
Price/Book	13.67	1.72	1.51
Price/Cash Flow	-54.40	-3.75	8.23
Prices/Earnings	-19.05	10.78	13.32
Price/Sales	7.43	13.80	12.84
Price/FCF	-54.40	-3.75	8.23
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-8.66	0.91	1.00
Operating Margin	37.21	0.46	0.33
ROA	36.59	< 0.005	< 0.005
ROE	0.03	0.04	40.43
ROIC	0.01	0.02	10.80
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.76	-0.24	217.30
Dividends QOQ	0.02	0.02	32.60
EBIT QOQ	-0.26	0.49	91.45
EPS QOQ	-0.30	0.52	73.35
FCF QOQ	0.33	-3.56	962.72
Revenue QOQ	-0.03	0.09	195.80
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	-343002.04	-100.00
Days Sales Outstanding (DSO)	250.33	278.63	11.31
Inventory Turnover	0.00	< 0.005	-100.00
Debt/Capitalization	0.57	0.65	14.41
Quick Ratio	4.47	0.74	-83.50
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	112.50	115.75	2.89
Cash	280.21	274.48	-2.04
Capex	0.00	0.00	0.00
Free Cash Flow	20.67	-53.01	156.48
Revenue	13.24	14.42	8.87
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.48	2.02	37.06
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	1025.21	10.73	-98.95
Naive Interpretation	Member

06 - Financial Health · Bad

Rating